Table 1.
Patient demographics.
| Characteristics | FOLFIRINOX | GA | Total |
|---|---|---|---|
|
| |||
| Total, N (%) | 34 (49) | 36 (51) | 70 (100) |
| Age, Y, median | 64 | 65 | 65 |
| Gender, N (%) | |||
| Male | 16 (47) | 21 (58) | 37 (53) |
| Female | 18 (53) | 15 (42) | 33 (47) |
| Race, N (%) | |||
| White | 30 (88) | 28 (78) | 58 (83) |
| Black | 2 (6) | 2 (6) | 4 (6) |
| Asian | 0 (0) | 5 (14) | 5 (7) |
| Other/unknown | 2 (6) | 1 (3) | 3 (4) |
| ECOG PS, N (%) | |||
| 0 | 12 (35) | 11 (31) | 23 (33) |
| 1 | 22 (65) | 24 (67) | 46 (66) |
| 2 | 0 (0) | 1 (3) | 1 (1) |
| Primary site | |||
| Head | 10 (29) | 12 (33) | 22 (31) |
| Body | 8 (24) | 14 (39) | 22 (31) |
| Tail | 16 (47) | 10 (28) | 26 (37) |
| Metastasis site | |||
| Liver | 27 (79) | 27 (75) | 54 (77) |
| Peritoneum | 13 (38) | 16 (44) | 29 (41) |
| Lung | 4 (12) | 7 (19) | 11 (16) |
| Other | 1 (3) | 3 (8) | 4 (6) |
| Number of metastatic sites | |||
| 1 | 24 (71) | 22 (61) | 46 (66) |
| 2 | 9 (26) | 11 (31) | 20 (29) |
| 3 | 1 (3) | 3 (8) | 4 (6) |